Literature DB >> 6131651

Alpha-adrenolytic properties of bromocriptine in dogs.

J L Montastruc, P Montastruc.   

Abstract

The effects of bromocriptine on dose-response curves to intravenously administered sympathomimetic agents (adrenaline, noradrenaline, phenylephrine and clonidine) were studied in normotensive anesthetized dogs. After pretreatment with bromocriptine (0.3 or 1 mg/kg i.v.) low doses of adrenaline showed a significant depressor action. In contrast, this drug failed to modify the variations in blood pressure induced by noradrenaline. Bromocriptine reduced the pressor effect of phenylephrine and the hypotensive action of clonidine. These results suggest that, in addition to dopaminergic stimulant properties, bromocriptine also possesses alpha-adrenolytic properties. The data obtained with phenylephrine and clonidine suggest that bromocriptine is a mixed alpha 1 and alpha 2 antagonist. The differences observed between adrenaline and noradrenaline are discussed in term of different subtypes (intra- and extra-synaptic) of alpha-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6131651

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  2 in total

1.  Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist.

Authors:  A F Haase; H E Greiner; C A Seyfried
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

2.  Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.

Authors:  Q A Mekki; P Turner
Journal:  Br J Ophthalmol       Date:  1985-12       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.